Research Update: Family Dollar Stores Inc. 'BBB-' Rating Off CreditWatch; Outlook Stable May 11

  • ID: 1802324
  • May 2011
  • Standard & Poors
1 of 3

We believe that a buyout of U.S. discount store operator Family Dollar by the Trian Group is less likely to occur in the near-to-intermediate term. Family Dollar's board of directors has rejected the unsolicited buyout offer from the Trian Group and has adopted a shareholder rights plan. We are removing the ratings from Credit Watch with negative implications and affirming all ratings, including the 'BBB-' corporate credit rating. The stable outlook reflects our belief that positive operating momentum, a disciplined store growth strategy, and a moderate financial policy will maintain credit measures in line with the rating, despite an increase in share repurchases and faster store growth plans. On May 23, 2011, Standard & Poor's Ratings Services removed its ratings...

Companies mentioned in this report are: Family Dollar Stores, Inc.
Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Product Type: Research Update
Research updates complement media releases. They offer more depth and detail than summary analyses by incorporating all information published in the media release. They are more up to date than summaries in that they are published simultaneously with media releases.

Note: Product cover images may vary from those shown
2 of 3

Family Dollar Stores, Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.